Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion

NCT07259928 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Proliferative Diabetic Retinopathy
Retinal Vein Occlusion

Interventions

BIOLOGICAL: ANXV

Sponsor

Annexin Pharmaceuticals AB